Clinical trial
Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid…
NCT00286871 · Duke University, Other · Completed
Key facts
| NCT number | NCT00286871 |
|---|---|
| Title | Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen |
| Official title | Steroid Avoidance in Hep C OLT |
| Lead sponsor | Duke University, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C, Organ Transplantation, Immunosuppression |
| Intervention type | Drug |
| Interventions | Neoral, Tacrolimus |
| Enrollment | 40 |
| Start date | Feb 1, 2006 |
| Completion | Feb 1, 2009 |
| First posted | Feb 6, 2006 |
| Last update posted | Sep 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: